Participate in the Cardiologist Education Conference

Doctors go through essential cardiologist education training for many years to learn about medicine and heart surgery before they become heart surgeons. But, the number of the doctors in comparison to patients is few. As the number of heart patients is growing, researchers and expert cardiologists are working hard to provide essential Cardiologist education to professionals and health-providers to close the gap in the ratio of expert heart doctors to patients. Cardiovascular disease killed 17.5 million people in 2012, that is 3 in every 10 deaths and this is expected to rise to 23.3 million by 2030.

Indeed cardiovascular disease is a major issue around the globe. All over the world, many organizations organize seminars and conferences so that they can develop new solutions for controlling the disease. There are institutions that give opportunities to renowned speakers to share their research work on Coronary Stenting in seminars. Also, authentic articles and journals on Coronary Stenting are published so that more doctors learn about the latest innovations in the medical field.

With the help of reviewed articles and practice guidelines, many professionals gain knowledge of Drug-Eluting Balloon Angioplasty and get in touch with the latest information in their field. The practice guides, review articles and case reports are carefully checked by experts before being published in medical journals. Knowledge of Drug-Eluting Balloon Angioplasty experts share their views in the form of theoretical discussions and original research. The aim of publishing all such information in journals is to keep cardiologists up to date with recent research and guidelines and to successfully treat and manage as many heart patients as possible more quickly. The seminars and conferences provide intensive training forcardiologists and keep them updated about high-tech medical equipment and its usage.

Read More

Advances in mitral valve disease treatment

Treatment of mitral valve disease is a very common condition, affecting about 3% of the population. Recent years have seen major advances in minimally invasive mitral valve surgery and several new catheter-based techniques are being clinically evaluated. Indeed, percutaneous therapy has emerged as an option for treatment of mitral valve disease including regurgitation and prolapse for selected, predominantly high-risk patients.

Many patients with symptomatic, severe mitral regurgitation never undergo surgery due to a deemed excessive surgical risk and complete endovascular surgery is therefore an exciting alternative for these patients. Several technologies are being investigated, most of them based on long-standing surgical techniques. Over 1,000 patients have been treated worldwide with the Mitraclip system for leaflet plication, for example. This device has gained the CE mark and there has been a shift in the spectrum of candidates suitable for this technique, as recent experiences have shown that adverse mitral anatomies and functional MR patients may also benefit from this form of complete endovascular surgery and device.

An overview of recent technology for mitral heart disease can be found on Radcliffe Cardiology’s website which has a strong focus on cardiologist education. Anatomic evaluation seems crucial in order to select the most suitable patient for the procedure and cardiac computed tomography angiography is probably the best tool for patient selection. Indeed, mitral regurgitation is a complex disease with many aetiologies and pathophysiologies and therefore it seems unlikely that a single device can fix the problem. The first challenge is in fact to really understand MV disease which is why focus on education for cardiologists is so important, then a combination of techniques will be necessary for a satisfactory MR repair. Close collaboration between interventional cardiologists, cardiac surgeons, imaging cardiologists, basic scientists and the industry is essential for these technologies to progress and become a real alternative for this group of patients.

Read More